Xiao-peng Tian
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial.
Journal: Journal of hematology & oncology
Published: January 29, 2025
Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML.
Journal: Frontiers in immunology
Published: August 26, 2024
Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia.
Journal: Frontiers in oncology
Published: July 20, 2022
Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
Journal: Computational and structural biotechnology journal
Published: June 24, 2022
Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients.
Journal: Frontiers in pharmacology
Published: March 08, 2022
Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation
Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation
Journal: Zhonghua yi xue za zhi
Published: June 13, 2013
Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 15, 2013
Monosomal karyotypes among 1147 Chinese patients with acute myeloid leukemia: prevalence, features and prognostic impact.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026